The European Medicines Agency EMA will leave London and relocate to Amsterdam because of Brexit, which is announced for 29 March 2019. Accomplishing this change of location without massive operational restrictions is an enormous task and detailed planning has already commenced. EMA has published an interactive tool the interested public can use to track the progress of the various relocation preparations. This interactive PDF document indicates the milestones scheduled for the relocation, the progress already made, and whether there are delays to the schedule.

In order to ensure full usability the tracking tool should not be opened in an internet browser but in a programme specifically designed to process PDF files (e.g. Acrobat Reader) that supports the interactive features.

EMA will update the interactive tracking tool whenever new planning steps or milestones will be reached.

Since the new building to be specifically constructed for EMA in Amsterdam is not expected to be ready before November 2019, EMA will initially move into temporary premises at the beginning of 2019.

Meanwhile EMA finds itself forced to temporarily scale back and suspend some activities because staff loss associated with the relocation will probably be higher than expected. Increasingly, those staff members who will not follow EMA to Amsterdam are already leaving the agency.

Update: As of 11 March 2019 EMA is operating from Amsterdam.